13 Things to Know About Medication During Pregnancy — From a Medical Perspective

5. Common Over-the-Counter Medications and Their Pregnancy Safety Profiles

Over-the-counter medications present unique challenges during pregnancy as they are readily accessible without prescription oversight, yet many carry important considerations for maternal and fetal safety that require careful evaluation. Acetaminophen (paracetamol) is widely considered the safest analgesic and antipyretic option during pregnancy, with extensive use data supporting its safety when used at recommended doses, though recent research has raised questions about potential associations with neurodevelopmental outcomes that warrant further investigation. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen present timing-specific risks, being generally avoided in the first trimester due to potential cardiovascular malformation risks and contraindicated in the third trimester due to effects on fetal ductus arteriosus closure and oligohydramnios. Aspirin requires special consideration, as low-dose aspirin (81mg) is actually recommended for certain high-risk pregnancies to prevent preeclampsia, while higher doses carry bleeding risks and should be avoided near delivery. Antihistamines show variable safety profiles, with first-generation antihistamines like chlorpheniramine and diphenhydramine having more safety data than newer formulations, though loratadine and cetirizine are increasingly considered acceptable options. Decongestants, particularly pseudoephedrine and phenylephrine, raise concerns about vasoconstriction and potential effects on placental blood flow, making non-pharmacological approaches preferable for nasal congestion. Antacids and acid reducers generally show good safety profiles, with calcium carbonate and magnesium-based antacids being preferred over aluminum-containing formulations. The key message for pregnant women is that "over-the-counter" does not mean "automatically safe during pregnancy," and consultation with healthcare providers before using any OTC medications ensures appropriate risk-benefit assessment and optimal maternal-fetal outcomes.

6. Prescription Medications Requiring Special Monitoring and Dose Adjustments

Many prescription medications require enhanced monitoring and dosage modifications during pregnancy due to the physiological changes that affect drug pharmacokinetics and the need to optimize maternal treatment while minimizing fetal exposure. Antiepileptic drugs exemplify this complexity, as pregnancy can alter drug clearance significantly, potentially leading to breakthrough seizures if levels drop too low, while maintaining the lowest effective dose minimizes teratogenic risks. Lamotrigine clearance can increase by 200-300% during pregnancy, necessitating frequent level monitoring and dose adjustments, with careful planning for postpartum dose reduction to prevent toxicity. Thyroid medications require close monitoring as thyroid hormone requirements typically increase during pregnancy, with TSH levels checked every 4-6 weeks and levothyroxine doses adjusted accordingly to prevent maternal hypothyroidism and its associated fetal complications. Insulin requirements in diabetic patients often change dramatically throughout pregnancy, with increased insulin resistance in the second and third trimesters requiring frequent glucose monitoring and dose adjustments to maintain optimal glycemic control. Warfarin presents particular challenges as it crosses the placenta and carries teratogenic risks, often necessitating conversion to heparin or low molecular weight heparin with careful monitoring of anticoagulation parameters. Lithium requires specialized monitoring due to changes in renal clearance during pregnancy and increased risks of cardiac malformations with first-trimester exposure, often requiring dose adjustments and enhanced cardiac monitoring. Immunosuppressive medications used in organ transplant recipients or autoimmune conditions require careful balance between preventing rejection or disease flares while minimizing fetal exposure, often involving multidisciplinary care teams. The principle underlying all these adjustments is that pregnancy is not a time to simply continue pre-pregnancy regimens unchanged, but rather requires proactive monitoring and adjustment to ensure optimal outcomes for both mother and fetus.